XBiotech (XBIT) Gains Following Post-IPO Pullback
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on Alphabet boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil prices rise on Trump timeline for Iran peace deal: after US elections
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
XBiotech (XBIT) IPO Opens Up 21%
April 15, 2015 11:17 AM EDTToday's IPO for XBiotech Inc., (Nasdaq: XBIT) opened for trading at $23 after pricing 4,000,000 shares of its common stock at an initial public offering price of $19.00 per share.
WR Hambrecht + Co is acting as the sole underwriter for the offering.
XBiotech is a leading developer... More
